GENINCODE
GEN inCode specializes in cardiovascular disease risk. Cardiovascular disease is the leading cause of death and disability worldwide. GEN inCode products combine genetic and clinical data to risk assess patients and provide healthcare practitioners with advanced clinical information to evaluate and predict the onset of cardiovascular disease. Our products help inform patients of their health risk enabling them to make behavioral or ‘lifestyle’ changes whilst providing doctors with greater ... genetic insight and clinical information to determine the most effective treatment pathway (precision medicine). GEN inCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies. Our molecular tests combine clinical algorithms and artificial intelligence to provide an advanced patient risk assessment to predict disease onset.
GENINCODE
Industry:
Biotechnology Health Care Life Science
Founded:
2018-01-01
Address:
Oxford, Oxfordshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.genincode.com
Total Employee:
11+
Status:
Active
Contact:
+44 7800 903435
Email Addresses:
[email protected]
Total Funding:
3.9 M GBP
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Metabolomic Diagnostics
Metabolomic Diagnostics specializes in the development of novel biomarker based diagnostic solutions for complex diseases
Renovacor
Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapy‑based treatments for cardiovascular disease.
RNAimmune
RNAimmune is a biopharmaceutical company specializing in the discovery and development of mRNA-based therapeutics and vaccines.
Current Employees Featured
Founder
Investors List
Maven Capital Partners
Maven Capital Partners investment in Private Equity Round - GENinCode
Maven Capital Partners
Maven Capital Partners investment in Private Equity Round - GENinCode
Official Site Inspections
http://www.genincode.com Semrush global rank: 5.08 M Semrush visits lastest month: 1.62 K
- Host name: 26.35.214.35.bc.googleusercontent.com
- IP address: 35.214.35.26
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "GENinCode"
Investor Centre | Genetic Testing For Personalised Health
Mr Puig Gilberte founded GENinCode in September 2018 and is the Group’s Chief Operating Officer. Prior to forming GENinCode, he worked for the Ferrer Group from 2006 through to …See details»
GENinCode
Jun 27, 2024 GENinCode is a U.K. limited company specializing in risk assessment and prediction of cardiovascular disease. Cardiovascular disease (CVD) is a broad disease …See details»
GENinCode - Crunchbase Company Profile & Funding
Organization. GENinCode . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Additionally, GENinCode is identified as a participant in the precision medicine market, …See details»
Board of Directors | Genetic Testing For Personalised
Jordi Puig – Chief Operations Officer Mr Puig Gilberte founded GENinCode in September 2018 and is the Group’s Chief Operating Officer. Prior to forming GENinCode, he worked for the Ferrer Group from 2006 through to 2018 …See details»
DIRECTORS - investors.genincode.com
At the end of the year, we bolstered the GENinCode US sales team and are now preparing to ‘soft launch’ the LIPID inCODE ® and CARDIO inCode Early Access Programs (EAPs). The EAPs …See details»
GENinCode Predictive Genetics - LinkedIn
GENinCode specializes in risk assessment and prediction of cardiovascular disease , thrombosis and familial hypercholesterolemia . Cardiovascular disease (CVD) is a broad disease classification ...See details»
GENinCode - Funding, Financials, Valuation & Investors
GENinCode is a genetic testing business specializing in the risk assessment and prediction of cardiovascular disease. Search Crunchbase. Start Free Trial . ... Which types of acquisition …See details»
GENinCode - Contacts, Employees, Board Members, Advisors
GENinCode is a genetic testing business specializing in the risk assessment and prediction of cardiovascular disease.See details»
Genetic Testing For Personalised Health Care and …
Oct 17, 2018 GENinCode UK Limited Oxford Science Park, John Eccles House Robert Robinson Avenue Oxford, OX4 4GP +44 (0)1865 676 125 click here. SPAIN. GENinCode S.L.U. Rambla Egara 235, 5ª planta C D, Terassa 08224 …See details»
Genincode PLC, GENI:LSE profile - FT.com - Financial Times
Nov 15, 2024 GENinCode Plc is a United Kingdom-based polygenics company focused on the prevention of cardiovascular disease and ovarian cancer. The Company operates business …See details»
GENinCode Plc (“GENinCode” or the “Company”)
GENinCode Plc www.genincode.com or via Walbrook PR Matthew Walls, CEO Paul Foulger, CFO Stifel Nicolaus Europe Limited (Nomad and Joint Broker) Tel: +44 (0)20 7710 7600 Alex …See details»
GENinCode announces major US commercialisation partnership
Oxford, UK. — 14, June 2021 — GENinCode UK Limited, the cardiovascular disease company focused on predictive genetics for the prevention of cardiovascular disease, announces its …See details»
Financial Reports | Genetic Testing For Personalised Health
Jun 30, 2021 GENinCode UK Limited Oxford Science Park, John Eccles House Robert Robinson Avenue Oxford, OX4 4GP +44 (0)1865 676 125. SPAIN. GENinCode S.L.U. Rambla …See details»
GEN inCode Announces Completion of £3m Institutional …
Sep 1, 2020 GENinCode UK Limited Oxford Science Park, John Eccles House Robert Robinson Avenue Oxford, OX4 4GP +44 (0)1865 676 125 click here. SPAIN. GENinCode S.L.U. Rambla …See details»
GEN inCode CEO and Key Executive Team | Craft.co
GEN inCode's Chief Executive Officer is Matthew Walls. Other executives include Jordi Puig, Chief Operations Officer; Paul Foulger, Chief Financial Officer and 4 others. See the full …See details»
GENinCode Appoints New Chairman | Genetic Testing For …
Jan 7, 2021 GENinCode UK Limited the privately-owned artificial intelligence cardiovascular disease company focused on the prevention of cardiovascular disease, announces today the …See details»
Corporate News - GENinCode
Jul 19, 2021 GENinCode plc is engaged in the risk assessment, prediction and prevention of cardiovascular disease ("CVD"). CVD is the leading cause of death worldwide accounting for …See details»
Collaboration with US healthcare provider for CARDIO inCode …
Jul 19, 2023 Matthew Walls, CEO of GENinCode Plc said: “ We are pleased to announce our first major US clinical collaboration with MedStar, which will focus on use of CIC-SCORE to …See details»
GEN inCode COVID-19 TESTING
GENinCode test products have been developed to help physicians make improved clinical decisions. By delivering comprehensive risk assessment we are able to stratify patients and …See details»